Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Karine Dufresne und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. Hauptthemen laut MEDLINE: Superantigens, Enterotoxins, Staphylococcus aureus, Bacterial Toxins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, CIHR, National Institutes of Health.
Abstract (Originalsprache)
Menstrual toxic shock syndrome (mTSS) is a rare but severe disorder associated with the use of menstrual products such as high-absorbency tampons and is caused by Staphylococcus aureus strains that produce the toxic shock syndrome toxin-1 (TSST-1) superantigen. Herein, we screened a library of 3920 small bioactive molecules for the ability to inhibit transcription of the TSST-1 gene without inhibiting the growth of S. aureus. The dominant positive regulator of TSST-1 is the SaeRS two-component system (TCS), and we identified phenazopyridine hydrochloride (PP-HCl) that repressed the production of TSST-1 by inhibiting the kinase function of SaeS. PP-HCl competed with ATP for binding of the kinase SaeS leading to decreased phosphorylation of SaeR and reduced expression of TSST-1 as well as several other secreted virulence factors known to be regulated by SaeRS. PP-HCl targets the virulence of S. aureus, and it also decreases the impact of TSST-1 on human lymphocytes without affecting the healthy vaginal microbiota. Our findings demonstrate the promising potential of PP-HCl as a therapeutic strategy against mTSS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada.
- Department of Biology, Georgetown University, Washington, District of Columbia, USA.
- Department of Microbiology and Immunology, University of Western Ontario, London, Ontario, Canada. Electronic address: john.mccormick@uwo.ca.
Förderung
- NIAID NIH HHS
- CIHR
- National Institutes of Health
- McMaster University
- Canadian Institutes of Health Research
Zitieren
APA
Dufresne, K., DiMaggio, D. A., Maduta, C. S., Brinsmade, S. R., & McCormick, J. K. (2024). Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107455
Vancouver
Dufresne K, DiMaggio DA, Maduta CS, Brinsmade SR, McCormick JK. Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107455
BibTeX
@article{Dufresne2024,
author = {Dufresne, Karine and DiMaggio, Dennis A and Maduta, Carla S and Brinsmade, Shaun R and McCormick, John K},
title = {Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107455}
}
EUVIMED